For example, in a nested case–control analysis of patients with type 2 diabetes receiving drug treatment, the treatment of GLP-1R agonists increased the risk of medullary thyroid cancer and thyroid cancer [189]. The gene discussed is GLP1R; the disease is thyroid gland carcinoma.